Literature DB >> 30120810

T-complex protein 1-ring complex enhances retrograde axonal transport by modulating tau phosphorylation.

Xu-Qiao Chen1, Fang Fang1, Jazmin B Florio1, Edward Rockenstein1, Eliezer Masliah1, William C Mobley1, Robert A Rissman1,2, Chengbiao Wu1,2.   

Abstract

The cytosolic chaperonin T-complex protein (TCP) 1-ring complex (TRiC) has been shown to exert neuroprotective effects on axonal transport through clearance of mutant Huntingtin (mHTT) in Huntington's disease. However, it is presently unknown if TRiC also has any effect on axonal transport in wild-type neurons. Here, we examined how TRiC impacted the retrograde axonal transport of brain-derived neurotrophic factor (BDNF). We found that expression of a single TRiC subunit significantly enhanced axonal transport of BDNF, leading to an increase in instantaneous velocity with a concomitant decrease in pauses for retrograde BDNF transport. The transport enhancing effect by TRiC was dependent on endogenous tau expression because no effect was seen in neurons from tau knockout mice. We showed that TRiC regulated the level of cyclin-dependent kinase 5 (CDK5)/p35 positively, contributing to TRiC-mediated tau phosphorylation (ptau). Expression of a single TRiC subunit increased the level of ptau while downregulation of the TRiC complex decreased ptau. We further demonstrated that TRiC-mediated increase in ptau induced detachment of tau from microtubules. Our study has thus revealed that TRiC-mediated increase in tau phosphorylation impacts retrograde axonal transport.
© 2018 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  TRiC/CCT chaperonin; axonal transport; hyperphosphorylation; tau

Mesh:

Substances:

Year:  2018        PMID: 30120810      PMCID: PMC6191364          DOI: 10.1111/tra.12610

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  89 in total

1.  A direct regulatory interaction between chaperonin TRiC and stress-responsive transcription factor HSF1.

Authors:  Daniel W Neef; Alex M Jaeger; Rocio Gomez-Pastor; Felix Willmund; Judith Frydman; Dennis J Thiele
Journal:  Cell Rep       Date:  2014-10-30       Impact factor: 9.423

2.  Pathogenic forms of tau inhibit kinesin-dependent axonal transport through a mechanism involving activation of axonal phosphotransferases.

Authors:  Nicholas M Kanaan; Gerardo A Morfini; Nichole E LaPointe; Gustavo F Pigino; Kristina R Patterson; Yuyu Song; Athena Andreadis; Yifan Fu; Scott T Brady; Lester I Binder
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

Review 3.  Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.

Authors:  Antero Salminen; Johanna Ojala; Kai Kaarniranta; Mikko Hiltunen; Hilkka Soininen
Journal:  Prog Neurobiol       Date:  2010-11-05       Impact factor: 11.685

4.  Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport.

Authors:  Chelsea T Tiernan; Benjamin Combs; Kristine Cox; Gerardo Morfini; Scott T Brady; Scott E Counts; Nicholas M Kanaan
Journal:  Exp Neurol       Date:  2016-06-30       Impact factor: 5.330

Review 5.  Abnormal hyperphosphorylation of tau: sites, regulation, and molecular mechanism of neurofibrillary degeneration.

Authors:  Jian-Zhi Wang; Yi-Yuan Xia; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

6.  CHIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival.

Authors:  Hideki Shimura; Daniel Schwartz; Steven P Gygi; Kenneth S Kosik
Journal:  J Biol Chem       Date:  2003-11-10       Impact factor: 5.157

7.  Cytosolic chaperonin prevents polyglutamine toxicity with altering the aggregation state.

Authors:  Akira Kitamura; Hiroshi Kubota; Chan-Gi Pack; Gen Matsumoto; Shoshiro Hirayama; Yasuo Takahashi; Hiroshi Kimura; Masataka Kinjo; Richard I Morimoto; Kazuhiro Nagata
Journal:  Nat Cell Biol       Date:  2006-09-17       Impact factor: 28.213

Review 8.  Chaperone signalling complexes in Alzheimer's disease.

Authors:  John Koren; Umesh K Jinwal; Daniel C Lee; Jeffrey R Jones; Cody L Shults; Amelia G Johnson; Laura J Anderson; Chad A Dickey
Journal:  J Cell Mol Med       Date:  2009-04       Impact factor: 5.310

9.  Hyperphosphorylation-induced tau oligomers.

Authors:  Khalid Iqbal; Cheng-Xin Gong; Fei Liu
Journal:  Front Neurol       Date:  2013-08-15       Impact factor: 4.003

10.  Disrupting CCT-β : β-tubulin selectively kills CCT-β overexpressed cancer cells through MAPKs activation.

Authors:  Yan-Jin Liu; Vathan Kumar; Yuan-Feng Lin; Po-Huang Liang
Journal:  Cell Death Dis       Date:  2017-09-14       Impact factor: 8.469

View more
  9 in total

Review 1.  The ATP-powered gymnastics of TRiC/CCT: an asymmetric protein folding machine with a symmetric origin story.

Authors:  Daniel Gestaut; Antonio Limatola; Lukasz Joachimiak; Judith Frydman
Journal:  Curr Opin Struct Biol       Date:  2019-04-09       Impact factor: 6.809

2.  Human Papillomavirus infection requires the CCT Chaperonin Complex.

Authors:  Marina Bugnon Valdano; Paola Massimi; Justyna Broniarczyk; David Pim; Michael Myers; Daniela Gardiol; Lawrence Banks
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

3.  Subcellular proteomics of dopamine neurons in the mouse brain.

Authors:  Benjamin D Hobson; Se Joon Choi; Eugene V Mosharov; Rajesh K Soni; David Sulzer; Peter A Sims
Journal:  Elife       Date:  2022-01-31       Impact factor: 8.140

Review 4.  The TRiCky Business of Protein Folding in Health and Disease.

Authors:  Heba Ghozlan; Amanda Cox; Daniel Nierenberg; Stephen King; Annette R Khaled
Journal:  Front Cell Dev Biol       Date:  2022-05-05

5.  IGF1R regulates retrograde axonal transport of signalling endosomes in motor neurons.

Authors:  Alexander D Fellows; Elena R Rhymes; Katherine L Gibbs; Linda Greensmith; Giampietro Schiavo
Journal:  EMBO Rep       Date:  2020-02-07       Impact factor: 8.807

Review 6.  The Molecular Chaperone CCT/TRiC: An Essential Component of Proteostasis and a Potential Modulator of Protein Aggregation.

Authors:  Julie Grantham
Journal:  Front Genet       Date:  2020-03-19       Impact factor: 4.599

7.  Myelin Pathology: Involvement of Molecular Chaperones and the Promise of Chaperonotherapy.

Authors:  Federica Scalia; Antonella Marino Gammazza; Everly Conway de Macario; Alberto J L Macario; Francesco Cappello
Journal:  Brain Sci       Date:  2019-10-30

8.  Dlec1 is required for spermatogenesis and male fertility in mice.

Authors:  Yu Okitsu; Mamoru Nagano; Takahiro Yamagata; Chizuru Ito; Kiyotaka Toshimori; Hideo Dohra; Wataru Fujii; Keiichiro Yogo
Journal:  Sci Rep       Date:  2020-11-03       Impact factor: 4.379

9.  Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.

Authors:  Xu-Qiao Chen; Ahmad Salehi; Matthew L Pearn; Cassia Overk; Phuong D Nguyen; Alexander M Kleschevnikov; Maria Maccecchini; William C Mobley
Journal:  Alzheimers Dement       Date:  2020-09-25       Impact factor: 21.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.